FES anticorps (AA 13-822)

N° du produit ABIN7870485

L’anticorps anti-FES Polyclonal Lapin est utilisé pour la détection de FES dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB et ELISA.

Aperçu rapide pour FES anticorps (AA 13-822) (ABIN7870485)

Antigène: FES (Feline Sarcoma Oncogene (FES))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FES est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-FES anticorps

Épitope: AA 13-822

Fonction: Fes/Fps Antibody

Purification: Antigen affinity purified

Immunogène: Recombinant human protein (amino acids H13-R822) was used as the immunogen for the Fes/Fps antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the Fes/Fps antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the Fes/Fps antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur FES

Antigène: FES (Feline Sarcoma Oncogene (FES))

Autre désignation: Fes/Fps

Sujet: FES (feline sarcoma oncogene) is an enzyme that in humans is encoded by the FES gene. This gene encodes the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. Non-onc intervening sequences were present in the human counterpart. The gene product has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia, but it is also involved in normal hematopoiesis. A truncated transcript has been identified that is generated utilizing a start site in one of the far downstream exons but a protein product associated with this transcript has not been identified.

UniProt: P07332

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2